Senior Director, US Marketing, Oncology, AML Franchise in Bernards, NJ at DSI

Date Posted: 5/16/2018

Job Snapshot

Job Description

Join a Legacy of Innovation 110 Years and Counting!
With over 100 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 15,000 employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In addition to a strong portfolio of medicines for hypertension and thrombotic disorders, under the Group’s 2025 Vision to become a “Global Pharma Innovator with a Competitive Advantage in Oncology,” Daiichi Sankyo research and development is primarily focused on bringing forth novel therapies in oncology, including immuno-oncology, with additional focus on new horizon areas, such as pain management, neurodegenerative diseases, heart and kidney diseases, and other rare diseases.

Job Summary
The Senior Director, US Marketing, Oncology, AML Franchise will lead the development and execution of US pre-commercialization strategies and plans in support of the assigned late-stage (Phase 3) oncology product(s). This position will lead and direct the CBT (Commercial Brand Team) and is responsible for the US A&P budget. This individual will also work cross functionally with clinical development, regulatory affairs, Global Marketing, Medical Affairs and other colleagues to maximize the commercial success of the product at launch and throughout its’ lifecycle pending FDA approval. The Senior Director, US Marketing, Oncology, AML Franchise will also be responsible for developing and executing the annual brand plan(s). He/she will lead the team that is accountable for achieving US financial targets upon commercialization.

Responsibilities:
  • Lead the development and maintenance of US marketing and commercialization plans for the late stage product(s). Plan to include, but not limited to: communication strategies, product positioning, messaging, promotional plans, sales and demand forecasts, life-cycle plan, sales force size and deployment, sales training plan, market access plans, customer segmentation and targeting.
  • Serve as the Leader of the Commercial Brand Team. Lead the team and provide appropriate direction and manage the implementation of the US marketing and commercialization plans for the late stage product.

  • Working with a cross-functional team, initiate and lead market development activities for the late stage product(s). Appropriately manage vendors and agencies utilized in the execution of market development activities.

  • Prepare and deliver presentations to senior management on all aspects of organizational launch readiness.

  • Lead and develop team members. Ensure all members receive sufficient coaching and mentoring to achieve objectives.

  • Collaborate with Global commercial and clinical team on key activities related to development and commercialization.

Qualifications:
Successful candidates will be able to meet the qualifications below with or without a reasonable accommodation.

Education/Experience:
Qualified candidates must have a Bachelor’s degree from an accredited college or university. MBA is preferred in marketing or finance.
  • Minimum 15 years pharmaceutical experience required, at least 7 of which are in product management or comparable function
  • Oncology marketing experience preferred
  • Oncology product launch experience preferred
  • Prior people management experience a plus
  • International \\ Global marketing experience a plus
  • Previous experience working in an alliance a plus
  • Sales, sales management experience a plus
  • Must have excellent oral, written, interpersonal and influencing skills
  • Must have the demonstrated ability to be creative and problem solve and to work independently
  • Strong financial and analytical skills required
  • Thorough understanding of the commercial evaluation process
  • Ability to operate effectively and efficiently on cross-functional, multi-national teams
  • Understanding of scientific issues as they impact product development and commercialization

Domestic travel as well as travel to Japan and Europe is required up to 30%.

Daiichi Sankyo, Inc. is an equal opportunity/affirmative action employer. Qualified applicants will receive consideration for employment without regard to sex, gender identity, sexual orientation, race, color, religion, national origin, disability, protected veteran status, age, or any other characteristic protected by law.